FDA product code ORI: Levetiracetam Assay

ORI is the FDA product code for levetiracetam assay. It is a Class II device, regulated under 21 CFR 862.3350 and reviewed by the Clinical Toxicology panel. FDA has cleared 2 510(k) submissions under ORI, 1 in the last five years. The average 510(k) review took 170 days (median 170); 193 days on average over the last three years.

Definition

For the quantitative determination of levetiracetam in human serum or plasma.

Classification

FieldValue
Device nameLevetiracetam Assay
Device classClass II
Regulation21 CFR 862.3350
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for ORI

YearClearancesAvg. review days
20241193

Top ORI applicants

ApplicantClearancesLatest
Ark Diagnostics, Inc.22024-02-27

Most recent ORI clearances

510(k)ApplicantDeviceDecision dateReview days
K232522Ark Diagnostics, Inc.ARK Levetiracetam II Assay2024-02-27193
K091653Ark Diagnostics, Inc.ARK LEVETIRACETAM ASSAY, ARK LEVETIRACETAM CALIBRATOR AND ARK LEVETIRACETAM CONTROL, MODELS 5024-0001-00, 5024-0002-002009-11-02146

Recalls for ORI devices

openFDA lists no recalls for product code ORI.

Frequently asked questions

What is FDA product code ORI?

ORI is the FDA product code for levetiracetam assay. It is a Class II device, regulated under 21 CFR 862.3350 and reviewed by the Clinical Toxicology panel.

What device class is ORI?

Class II, regulation 21 CFR 862.3350. Typical premarket route: 510(k).

How long does a 510(k) take for product code ORI?

Across 2 cleared submissions the average was 170 days from receipt to decision (median 170).

Which companies have the most ORI clearances?

Ark Diagnostics, Inc. (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Toxicology product codes · FDA product code lookup